Literature DB >> 9160550

Patient Stage of Change predicts outcome in a panic disorder medication trial.

B D Beitman1, N C Beck, W E Deuser, C S Carter, J R Davidson, R J Maddock.   

Abstract

OBJECTIVE: The authors test the hypothesis that patient readiness to change predicts outcome in a placebo-controlled medication trial.
METHOD: Out-patients with panic disorder and agoraphobia completed the Stages of Change (SOC) questionnaire, a measure of readiness to change, before being randomly assigned either sustained release (SR) adinazolam or placebo in a 4 week double-blind trial.
RESULTS: In the "intent to treat" analysis, for the 202 subjects who made at least one visit after baseline, adinazolam SR was significantly more effective than placebo on most major outcome measures. Of the 126 subjects who completed the SOC questionnaire, regression analyses showed significant correlations between SOC scores and all 5 outcome measures. In a second analysis, cluster membership based on SOC scores was predictive of outcome on 3 of 5 measures. In each statistical analysis, subjects who were not predisposed to change as measured by the SOC were significantly less likely to change.
CONCLUSIONS: Patient readiness to change was strongly correlated with outcome in a placebo-controlled panic disorder trial with an effective medication. In this study, the SOC category, Precontemplation (i.e., those subjects who reported the belief that they had no problem) were less likely to change compared to those who believed that they had a problem.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 9160550     DOI: 10.1002/anxi.3070010205

Source DB:  PubMed          Journal:  Anxiety        ISSN: 1070-9797


  3 in total

1.  Are antidepressants effective in the acute and long-term treatment of depression? Sic et Non.

Authors:  Ronald Pies
Journal:  Innov Clin Neurosci       Date:  2012-05

2.  Pretreatment Intervention Increases Treatment Outcomes for Patients with Anxiety Disorders.

Authors:  Julia D Buckner; Kiara R Cromer; Katherine A Merrill; Michael A Mallott; Norman B Schmidt; Cristina Lopez; Jill M Holm-Denoma; Thomas E Joiner
Journal:  Cognit Ther Res       Date:  2009

3.  Benzodiazepines versus placebo for panic disorder in adults.

Authors:  Johanna Breilmann; Francesca Girlanda; Giuseppe Guaiana; Corrado Barbui; Andrea Cipriani; Mariasole Castellazzi; Irene Bighelli; Simon Jc Davies; Toshi A Furukawa; Markus Koesters
Journal:  Cochrane Database Syst Rev       Date:  2019-03-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.